01 Introduction
01 Introduction
Office
#
Office Hours
E - mail
230
Sun 12-1
Tue 11-12
Course Objectives :
1) Understanding mathematical background
for modeling of the concentration time
relationships for the different routes of
administration.
2) Designing dosing regimens by relating
plasma concentration of drugs to their
pharmacological and toxicological action,
3) Understanding the concept of therapeutic
drug monitoring for drugs with narrow
therapeutic range or high toxicity.
2
Learning Outcomes :
A)
Knowledge and understanding
A1) Understanding mathematics of the time course of
Absorption, Distribution, Metabolism, and Excretion
(ADME) of drugs in the body.
A2) Understanding Individualization of therapy and
therapeutic drug monitoring.
B)
Intellectual skills (cognitive and analytical)
B1) Utilization of mathematics of the time course of
Absorption, Distribution, Metabolism, and Excretion
(ADME) of drugs in the body for dosage optimization.
B2) Developing dosing regimens for the
individualization of therapy for the patient
3
C)
Subject specific skills
C1) Fitting concentration time profiles and estimating
pharmacokinetic parameters.
C3) Designing dosing regimens in case of renal and
hepatic dysfunction.
D)
Transferable Skills
D1) Communicating the dosage adjustment with
physicians.
D2) Suggesting therapeutic monitoring plans.
Teaching Methods :
1)
Lectures
2)
Computer software (demo)
3)
Case Studies
4
Midterm exam
Quizzes and HWs
Final exam
40%
10%
50%
1. Introduction
2. The one-compartment open model with an intravenous bolus dose.
Plasma data; elimination rate constant, AUC, elimination half-life, volume
of distribution and clearance
Urinary data; excretion rate constant and half-life, elimination rate
constant
3. The one-compartment open model with an intravenous infusion.
Continues infusion, Infusion with a bolus dose, post infusion
4. The one-compartment open model with absorption and elimination;
Absorption rate constant, calculation of F, method of residuals, flip-flop
kinetics
5. The one-compartment open model with multiple dosing kinetics;
Multiple dosing IV and oral, multiple dosing factor, accumulation factor,
loading dose, and average concentration.
6. Designing dosing regimens
7. Dosage adjustment in renal failure. (Aminoglycosides)
8. The two-compartment open model with intravenous administration.
9. Non-linear pharmacokintics
Michaels-Mention kinetics, methods to obtain Vmax and Km (Phenytoin).
10. Pharmacodynamics
Linear models, E-max and time dependent response.
11. Therapeutic Drug Monitoring.
6
12. Bioequivalence revisited.
Textbook:
Applied biopharmaceutics and pharmacokinetics
Shargel and Yu, 5th edition, 2005
References:
1) Pharmacokinetics: processes, mathematics, and applications
2nd edition, Welling, P.G.., 1997
2) Handbook of Basic Pharmacokinetics
Wolfgang Ritschel, 6th edition, 2004
3) Clinical pharmacokinetics: concepts and applications
Rowland and Tozer, 3rd edition, 1995
Useful Web Sites
1) PHARMACOKINETICS LECTURE NOTES ONLINE
http://www.healthsci.utas.edu.au/pharmacy/kinetics/main.htm
2) University of Alberta/ Dr. Jamali
http://www.pharmacy.ualberta.ca/pharm415/contents.htm
3) A First Course in Pharmacokinetics and Biopharmaceutics
http://www.boomer.org/c/p1/
7
Pharmacokinetics: Introduction
Dr Mohammad Issa
What is pharmacokinetics?
What is pharmacokinetics?
10
11
14
Applications of pharmacokinetics
bioavailability measurements
effects of physiological and pathological conditions
on drug disposition and absorption
dosage adjustment of drugs in disease states, if
and when necessary
correlation of pharmacological responses with
administered doses
evaluation of drug interactions
clinical prediction: using pharmacokinetic
parameters to design a dosing regimen and thus
provide the most effective drug therapy
15
Applications of pharmacokinetics
Applications of pharmacokinetics
Applications of pharmacokinetics
18
drug A drug B
If the amount of drug A is decreasing with respect to time (that is, the
reaction is going in a forward direction), then the rate of this reaction
can be expressed as
dA
dt
Since the amount of drug B is increasing with respect to time, the rate
of the reaction can also be expressed as
dB
dt
19
Zero-Order Reactions
dA
k *
dt
Zero-Order Reactions
21
Slope = -K*
22
Conc.
(mg/L)
100
90
85
75
70
23
24
y = -2.5x + 100
2
R =1
100
conc (mg/L)
80
60
40
20
0
0
10
12
14
time (hr)
25
26
First-order Reactions
dA
K rate
A constant
where k is the first-order
dt
27
First-Order Reactions
A A0 e k *t
ln( A) ln( A0 ) k * t
28
29
30
Nonlinear kinetics
Nonlinear kinetics
32
Nonlinear kinetics
Nonlinear kinetics:
dC
C
Vmax
dt
Km C
Linear kinetics:
dC
K C
dt
33
Linear vs nonlinear PK
Linear PK
Nonlinear PK
3-The pharmacokinetic
parameters such as the half-life,
total body clearance and volume
of distribution are constant and
do not depend on the drug conc
3-The pharmacokinetic
parameters such as the half-life,
total body clearance and volume
of distribution are concdependant
Laplace transformation
Optional material
35
Laplace transformation
36
2.
3.
4.
Transform
sX X 0
dX/dt
K (constant)
K
s
X (variable)
KX (K is constant)
where s is the laplace operator,
KX
X is the laplace integral
38
39
40
dA
k *
dt
Derive the equation that describe
the amount of drug X??
41
dX
k *
dt
2.
k*
sX X 0
s
42
X0 k *
X
2
s
s
4.
X (t ) X 0 k * t
43
44
45